Halcinonide
Back to searchMolecule Structure
Scientific Name
Halcinonide
Description of the Drug
Halcinonide is a corticosteroid used for the management and symptomatic relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06786
http://www.drugbank.ca/drugs/DB06786
Brand Name(s)
Halog, Halog-e
Company Owner(s)
Bristol Myers Squibb, Sun Pharmaceutical Industries Inc, Westwood Squibb Pharmaceuticals Inc, Glasshouse Pharmaceuticals Ltd Canada, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4335 | |
| DrugBank | DB06786 | |
| PubChem: Thomson Pharma | 14906724 | |
| PubChem | 443943 | |
| LINCS | LSM-3832 | |
| Nikkaji | J3.398G | |
| BindingDB | 50240097 | |
| EPA CompTox Dashboard | DTXSID6045375 | |
| DrugCentral | 4507 | |
| ChemicalBook | CB9106428 | |
| rxnorm | HALOG | HALCINONIDE |
| ChEBI | 31663 | |
| ZINC | ZINC000004213474 |
